No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs565739597 |
chr17:15466638-15466639 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs535281905 |
chr17:15466642-15466643 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs28495834 |
chr17:15466704-15466705 |
Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
4 |
rs377288976 |
chr17:15466713-15466714 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs191004702 |
chr17:15466734-15466735 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs575245116 |
chr17:15466750-15466751 |
Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs369802859 |
chr17:15466756-15466757 |
Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs537729205 |
chr17:15466762-15466763 |
Active TSS
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs557344309 |
chr17:15466773-15466774 |
Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs377260184 |
chr17:15466783-15466784 |
Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs370528394 |
chr17:15466799-15466800 |
Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs373468170 |
chr17:15466803-15466804 |
Active TSS Weak transcription
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs143779011 |
chr17:15466822-15466823 |
Active TSS Weak transcription
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs184239223 |
chr17:15466835-15466836 |
Active TSS Weak transcription
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs572995013 |
chr17:15466842-15466843 |
Active TSS Weak transcription
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs540866759 |
chr17:15466872-15466873 |
Active TSS Weak transcription
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs186668025 |
chr17:15466882-15466883 |
Active TSS Weak transcription
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs192020500 |
chr17:15466893-15466894 |
Active TSS Weak transcription
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs560732350 |
chr17:15466916-15466917 |
Active TSS Weak transcription
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs182828689 |
chr17:15467048-15467049 |
Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs550070342 |
chr17:15467070-15467071 |
Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs563401591 |
chr17:15467079-15467080 |
Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs532142577 |
chr17:15467080-15467081 |
Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs551883083 |
chr17:15467084-15467085 |
Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs187087515 |
chr17:15467086-15467087 |
Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs565821921 |
chr17:15467103-15467104 |
Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs189527670 |
chr17:15467107-15467108 |
Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs182227581 |
chr17:15467185-15467186 |
Active TSS Weak transcription Enhancers
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs574272596 |
chr17:15467188-15467189 |
Active TSS Weak transcription Enhancers
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs534693854 |
chr17:15467196-15467197 |
Active TSS Weak transcription Enhancers
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs548829724 |
chr17:15467243-15467244 |
Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs568695282 |
chr17:15467296-15467297 |
Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs537215382 |
chr17:15467383-15467384 |
Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs557646306 |
chr17:15467400-15467401 |
Active TSS Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs371562106 |
chr17:15467412-15467413 |
Active TSS Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs574609252 |
chr17:15467494-15467495 |
Active TSS Weak transcription Enhancers Flanking Active TSS
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs374665077 |
chr17:15467499-15467500 |
Active TSS Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs142786129 |
chr17:15467545-15467546 |
Active TSS Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs540207173 |
chr17:15467550-15467551 |
Active TSS Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs377722032 |
chr17:15467573-15467574 |
Active TSS Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs573033732 |
chr17:15467576-15467577 |
Active TSS Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs186789599 |
chr17:15467710-15467711 |
Enhancers Weak transcription Active TSS Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs193090503 |
chr17:15467713-15467714 |
Enhancers Weak transcription Active TSS Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|